Search

everythinglearnresearchcommunity

for

Search:↓

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Somatostatin may help protect hair follicles from immune attacks.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Apremilast did not work for treating severe alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Sorafenib may cause hair loss in a way similar to alopecia areata.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

ILC1 cells contribute to hair loss in alopecia areata.

Stem cells help remove dead cells to keep tissues healthy by balancing cell replacement and clearance.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.